SCHEMBL30954071

SCHEMBL30954071

COc1c(Cl)cc2c(c1C(=O)O)OCCN2C(C)C

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.40
HSD17B10 Q99714 2/20 0.40
ALDH1A1 P00352 1/20 0.40
TPMT P51580 1/20 0.35
NOTUM Q6P988 1/20 0.34
TAS1R3 Q7RTX0 1/20 0.34
TAS1R1 Q7RTX1 1/20 0.34
TAS1R2 Q8TE23 1/20 0.34
MAPT P10636 1/20 0.34
DRD3 P35462 5/20 0.34
CNR1 P21554 1/20 0.33
DRD2 P14416 3/20 0.33
DRD1 P21728 3/20 0.33
DRD4 P21917 3/20 0.33
DRD5 P21918 3/20 0.33
CYP1A2 P05177 1/20 0.32
CYP2D6 P10635 1/20 0.32
CYP2C9 P11712 1/20 0.32
CYP2C19 P33261 1/20 0.32
KMT2A Q03164 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27434865 1.00 KDM4E (0.40) KDM4EHSD17B10ALDH1A1TPMTNOTUM
SCHEMBL27434847 0.89 TAS1R3 (0.36) KDM4EHSD17B10NOTUMTAS1R3TAS1R1
SCHEMBL27432464 0.84 KDM4E (0.43) KDM4EHSD17B10ALDH1A1TPMTNOTUM
SCHEMBL30954108 0.84 KDM4E (0.43) KDM4EHSD17B10ALDH1A1TPMTNOTUM
SCHEMBL30954160 0.81 KDM4E (0.40) KDM4EHSD17B10ALDH1A1TPMTDRD3
SCHEMBL27435335 0.81 KDM4E (0.40) KDM4EHSD17B10ALDH1A1TPMTDRD3
SCHEMBL30954043 0.80 KDM4E (0.41) KDM4EHSD17B10ALDH1A1TPMTTAS1R3
SCHEMBL27432942 0.80 KDM4E (0.41) KDM4EHSD17B10ALDH1A1TPMTTAS1R3
SCHEMBL27435528 0.77 KCNA3 (0.41) KDM4EHSD17B10ALDH1A1NOTUMDRD3
SCHEMBL30954070 0.76 S1PR1 (0.34) ALDH1A1NOTUMMAPTDRD2CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4630412-A1 COMPOUNDS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS NMD Pharma A/S (DK) 2025-10-15 EP claimed
WO-2024121130-A1 COMPOUNDS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS NMD PHARMA A/S (DK) 2024-06-13 WO claimed
EP-4630412-A1 COMPOUNDS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS NMD Pharma A/S (DK) 2025-10-15 EP disclosed
WO-2024121130-A1 COMPOUNDS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS NMD PHARMA A/S (DK) 2024-06-13 WO disclosed